The dose–response effects of arachidonic acid on primary human skeletal myoblasts and myotubes

References

• Hanna VS, Hafez EAA. Synopsis of arachidonic acid metabolism: a review. J Adv Res. 2018;11:23–16.
   PubMed Web of Science ®Google Scholar
• Brash AR. Arachidonic acid as a bioactive molecule. J Clin Invest. 2001;107(11):1339–1345.
   PubMed Web of Science ®Google Scholar
• Tallima H, El Ridi R. Arachidonic acid: physiological roles and potential health benefits - A review. J Adv Res. 2018;11:33–41.
   PubMed Web of Science ®Google Scholar
• Velica P, Bunce CM. Prostaglandins in muscle regeneration. J Muscle Res Cell Motil. 2008;29(6–8):163–167.
   PubMed Web of Science ®Google Scholar
• Markworth JF, Cameron-Smith D. Arachidonic acid supplementation enhances in vitro skeletal muscle cell growth via a COX-2-dependent pathway. Am J Physiol Cell Physiol. 2013;304(1):C56–67.
   PubMed Web of Science ®Google Scholar
• Abdelmoez AM, Sardon Puig L, Smith JAB, et al. Comparative profiling of skeletal muscle models reveals heterogeneity of transcriptome and metabolism. Am J Physiol Cell Physiol. 2020;318(3):C615–C626.
   PubMed Web of Science ®Google Scholar
• Mahfouz R, Khoury R, Blachnio-Zabielska A, et al. Characterising the inhibitory actions of ceramide upon insulin signaling in different skeletal muscle cell models: a mechanistic insight. PLoS One. 2014;9(7):e101865.
   PubMed Web of Science ®Google Scholar
• Sarabia V, Ramlal T, Klip A. Glucose uptake in human and animal muscle cells in culture. Biochem Cell Biol. 1990;68(2):536–542.
   PubMed Web of Science ®Google Scholar
• De Souza EO, Lowery RP, Wilson JM, et al. Effects of arachidonic acid supplementation on acute anabolic signaling and chronic functional performance and body composition adaptations. PLoS One. 2016;11(5):e0155153.
   PubMed Web of Science ®Google Scholar
• Markworth JF, D’souza RF, Aasen KMM, et al. Arachidonic acid supplementation transiently augments the acute inflammatory response to resistance exercise in trained men. J Appl Physiol. 2018;125(1985):271–286.
   PubMedGoogle Scholar
• Mitchell CJ, D’souza RF, Figueiredo VC, et al. Effect of dietary arachidonic acid supplementation on acute muscle adaptive responses to resistance exercise in trained men: a randomized controlled trial. J Appl Physiol. 2018;124(4):1080–1091.
   PubMed Web of Science ®Google Scholar
• Roberts MD, Iosia M, Kerksick CM, et al. Effects of arachidonic acid supplementation on training adaptations in resistance-trained males. J Int Soc Sports Nutr. 2007;4(1):21.
   PubMedGoogle Scholar
• Matheny RW Jr., Lynch CM, Leandry LA. Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110beta-deficient myoblasts is mediated by PI3K p110alpha and mTORC2. Growth Factors. 2012;30(6):367–384.
   PubMed Web of Science ®Google Scholar
• Matheny RW Jr., Riddle-Kottke MA, Leandry LA, et al. Role of phosphoinositide 3-OH kinase p110beta in skeletal myogenesis. Mol Cell Biol. 2015;35(7):1182–1196.
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–675.
   PubMed Web of Science ®Google Scholar
• Matheny RW Jr., Geddis AV, Abdalla MN, et al. AKT 2 is the predominant AKT isoform expressed in human skeletal muscle. Physiol Rep. 2018;6(6):e13652.
   PubMed Web of Science ®Google Scholar
• Risha MA, Siengdee P, Dannenberger D, et al. PUFA treatment affects C2C12 myocyte differentiation, myogenesis related genes and energy metabolism. Genes (Basel). 2021;12.
   PubMed Web of Science ®Google Scholar
• Lee JH, Tachibana H, Morinaga Y, et al. Modulation of proliferation and differentiation of C2C12 skeletal muscle cells by fatty acids. Life Sci. 2009;84(13–14):415–420.
   PubMed Web of Science ®Google Scholar
• Leng X, Jiang H. Effects of arachidonic acid and its major prostaglandin derivatives on bovine myoblast proliferation, differentiation, and fusion. Domest Anim Endocrinol. 2019;67:28–36.
   PubMed Web of Science ®Google Scholar
• Briolay A, Jaafar R, Nemoz G, et al. Myogenic differentiation and lipid-raft composition of L6 skeletal muscle cells are modulated by PUFAs. Biochim Biophys Acta. 2013;1828(2):602–613.
   PubMed Web of Science ®Google Scholar
• Markworth JF, Cameron-Smith D. Prostaglandin F 2α stimulates PI3K/ERK/mTOR signaling and skeletal myotube hypertrophy. Am J Physiol Cell Physiol. 2011;300(3):C671–682.
   PubMed Web of Science ®Google Scholar
• Gu H, Fang YJ, He YL, et al. Modulation of muscle rNa v 1.4 Na + channel isoform by arachidonic acid and its non-metabolized analog. J Cell Physiol. 2009;219(1):173–182.
   PubMed Web of Science ®Google Scholar
• Kehl SJ. Eicosatetraynoic acid (ETYA), a non-metabolizable analogue of arachidonic acid, blocks the fast-inactivating potassium current of rat pituitary melanotrophs. Can J Physiol Pharmacol. 2001;79(4):338–345.
   PubMed Web of Science ®Google Scholar
• Matheny RW,KAL, Geddis AV, Roberts BM. Celecoxib impairs primary human myoblast proliferation and differentiation independent of cyclooxygenase 2 inhibition. Physiol Rep. 2022;10(21):e15841.
   Web of Science ®Google Scholar
• Greaves MW, Mcdonald-Gibson W. Prostaglandin biosynthesis by human skin and its inhibition by corticosteroids. Br J Pharmacol. 1972;46(1):172–175.
   PubMed Web of Science ®Google Scholar
• Hong SL, Levine L. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci U S A. 1976;73(5):1730–1734.
   PubMed Web of Science ®Google Scholar
• Tashjian AH Jr., Voelkel EF, Mcdonough J, et al. Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells. Nature. 1975;258(5537):739–741.
   PubMed Web of Science ®Google Scholar
• Belanto JJ, Diaz-Perez SV, Magyar CE, et al. Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation. Neuromuscul Disord. 2010;20(2):111–121.
   PubMed Web of Science ®Google Scholar
• Bruscoli S, Donato V, Velardi E, et al. Glucocorticoid-induced leucine zipper (GILZ) and long GILZ inhibit myogenic differentiation and mediate anti-myogenic effects of glucocorticoids. J Biol Chem. 2010;285(14):10385–10396.
   PubMed Web of Science ®Google Scholar
• Bond P. Regulation of mTORC1 by growth factors, energy status, amino acids and mechanical stimuli at a glance. J Int Soc Sports Nutr. 2016;13(1):8.
   PubMedGoogle Scholar
• Schiaffino S, Dyar KA, Ciciliot S, et al. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 2013;280(17):4294–4314.
   PubMed Web of Science ®Google Scholar